Palvella Therapeutics (PVLA) Other Non Operating Income (2016 - 2024)
Historic Other Non Operating Income for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $1.7 million.
- Palvella Therapeutics' Other Non Operating Income rose 29339.62% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $771000.0, marking a year-over-year increase of 828.65%. This contributed to the annual value of $1.1 million for FY2024, which is 5449.44% up from last year.
- Latest data reveals that Palvella Therapeutics reported Other Non Operating Income of $1.7 million as of Q4 2024, which was up 29339.62% from -$568000.0 recorded in Q3 2024.
- Palvella Therapeutics' Other Non Operating Income's 5-year high stood at $1.7 million during Q4 2024, with a 5-year trough of -$1.8 million in Q4 2020.
- In the last 5 years, Palvella Therapeutics' Other Non Operating Income had a median value of $86000.0 in 2022 and averaged $76700.0.
- Its Other Non Operating Income has fluctuated over the past 5 years, first crashed by 233454.55% in 2020, then surged by 157333.33% in 2021.
- Palvella Therapeutics' Other Non Operating Income (Quarter) stood at -$1.8 million in 2020, then skyrocketed by 120.62% to $378000.0 in 2021, then crashed by 185.98% to -$325000.0 in 2022, then soared by 230.46% to $424000.0 in 2023, then skyrocketed by 293.4% to $1.7 million in 2024.
- Its Other Non Operating Income was $1.7 million in Q4 2024, compared to -$568000.0 in Q3 2024 and -$271000.0 in Q2 2024.